Protara Therapeutics, Inc. (TARA)
NASDAQ: TARA · Real-Time Price · USD
3.830
-0.160 (-4.01%)
At close: Aug 28, 2026, 4:00 PM EDT
3.820
-0.010 (-0.26%)
After-hours: Aug 28, 2026, 7:30 PM EDT
Protara Therapeutics Market Cap
Protara Therapeutics has a market cap or net worth of $225.74 million as of August 28, 2026. Its market cap has increased by 81.15% in one year.
Market Cap
225.74M
Enterprise Value
66.64M
1-Year Change
81.15%
Ranking
Category
Stock Price
$3.83
ChartMarket Cap Chart
Since January 10, 2020, Protara Therapeutics's market cap has increased from $173.16M to $225.74M, an increase of 30.37%. That is a compound annual growth rate of 4.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 225.74M | -20.96% |
| Dec 31, 2025 | 285.62M | 12.67% |
| Dec 31, 2024 | 253.49M | 1,089.52% |
| Dec 29, 2023 | 21.31M | -29.43% |
| Dec 30, 2022 | 30.20M | -60.18% |
| Dec 31, 2021 | 75.84M | -72.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Atrium Therapeutics | 233.32M |
| Tonix Pharmaceuticals Holding | 233.08M |
| Minerva Neurosciences | 231.10M |
| Greenwich LifeSciences | 230.01M |
| Sol-Gel Technologies | 225.28M |
| Keros Therapeutics | 218.69M |
| Voyager Therapeutics | 218.13M |
| Coherus Oncology | 217.85M |